360iResearch Logo
Global Meningococcal Vaccines Market
Report Code: MRR-2AA1024 | Publishing Date: August 2020 | Number of Pages: 226

The Global Meningococcal Vaccines Market to grow from USD 4,190.35 Million in 2019 to USD 8,033.15 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 11.45%.

Market Segmentation & Coverage:

The research report categorizes the Meningococcal Vaccines Market to forecast the revenues and analyze the trends in each of the following segments:

"The Conjugate Vaccines is projected to witness the highest growth during the forecast period"

Based on Type, the Meningococcal Vaccines Market studied across Combination Vaccines, Conjugate Vaccines, Men B Vaccines, and Polysaccharide Vaccines. The Combination Vaccines further studied across MenHibrix and Menitorix. The Conjugate Vaccines further studied across Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, and NmVac4-DT. The Men B Vaccines further studied across Bexsero and Trumenba. The Polysaccharide Vaccines further studied across Mencevax, Menomune, and NmVac4. The Men B Vaccines commanded the largest size in the Meningococcal Vaccines Market in 2019, followed by the Polysaccharide Vaccines. On the other hand, the Conjugate Vaccines expected to grow at the fastest CAGR during the forecast period, followed by the Polysaccharide Vaccines.

"The Intramuscular is projected to witness the highest growth during the forecast period"

Based on Category, the Meningococcal Vaccines Market studied across Intramuscular and Subcutaneous. The Intramuscular commanded the largest size in the Meningococcal Vaccines Market in 2019, followed by the Subcutaneous. On the other hand, the Intramuscular expected to grow at the fastest CAGR during the forecast period, followed by the Subcutaneous.

"The Pediatric Clinic is projected to witness the highest growth during the forecast period"

Based on End User, the Meningococcal Vaccines Market studied across Hospital Pharmacies, Pediatric Clinic, and Retail Pharmacies. The Hospital Pharmacies commanded the largest size in the Meningococcal Vaccines Market in 2019, followed by the Pediatric Clinic. On the other hand, the Pediatric Clinic expected to grow at the fastest CAGR during the forecast period, followed by the Retail Pharmacies.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Meningococcal Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Meningococcal Vaccines Market in 2019, followed by the Americas. On the other hand, the Asia-Pacific expected to grow at the fastest CAGR during the forecast period, followed by the Americas.

Market Dynamics:

The factors attributing to the growth of the market are increasing incidence of meningitis across the world, presence of various government and healthcare interventions for the awareness of meningococcal diseases, and rising r&d activities and vaccines developments in the pipeline. However, some factors such as stringent government regulations for the approval of vaccines may hinder the market growth. The Meningococcal Vaccines Market expected to showcase the opportunities such as incidence of bacterial meningitis in emerging countries and elevation of collaborations and partnerships to support the development of the vaccines. Soon market may face the possible challenges in the growth due to high cost associated with the development of the meningococcal vaccines. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch Competitive Strategic Window:

The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

360iResearch FPNV Positioning Matrix:

The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Meningococcal Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Company Usability Profiles:

The Meningococcal Vaccines Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Meningococcal Vaccines Market, including Bio-Manguinhos, Chongqing Zhifei Biological Products Co., Ltd., GlaxoSmithKline PLC, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Ltd., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd., and Walvax Biotechnology Co., Ltd..

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
      8. Repeat: Report Update
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
  3. Executive Summary
    1. Market Outlook
    2. Type Outlook
    3. Category Outlook
    4. End User Outlook
    5. Geography Outlook
    6. Competitor Outlook
  4. Market Overview
    1. Introduction
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Increasing incidence of meningitis across the world
      2. Presence of various government and healthcare interventions for the awareness of Meningococcal diseases
      3. Rising R&D activities and vaccines developments in the pipeline
    3. Restraints
      1. Stringent government regulations for the approval of vaccines
    4. Opportunities
      1. Incidence of bacterial meningitis in emerging countries
      2. Elevation of collaborations and partnerships to support the development of the vaccines
    5. Challenges
      1. High cost associated with the development of the meningococcal vaccines
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
  7. Global Meningococcal Vaccines Market, By Type
    1. Introduction
    2. Combination Vaccines
      1. MenHibrix
      2. Menitorix
    3. Conjugate Vaccines
      1. Menactra
      2. MenAfriVac
      3. Meningitec
      4. Menjugate
      5. Menveo
      6. NeisVac-C
      7. Nimenrix
      8. NmVac4-DT
    4. Men B Vaccines
      1. Bexsero
      2. Trumenba
    5. Polysaccharide Vaccines
      1. Mencevax
      2. Menomune
      3. NmVac4
  8. Global Meningococcal Vaccines Market, By Category
    1. Introduction
    2. Intramuscular
    3. Subcutaneous
  9. Global Meningococcal Vaccines Market, By End User
    1. Introduction
    2. Hospital Pharmacies
    3. Pediatric Clinic
    4. Retail Pharmacies
  10. Global Meningococcal Vaccines Market, By Geography
    1. Introduction
    2. Americas
      1. Argentina
      2. Brazil
      3. Canada
      4. Mexico
      5. United States
    3. Asia-Pacific
      1. Australia
      2. China
      3. India
      4. Indonesia
      5. Japan
      6. Malaysia
      7. Philippines
      8. South Korea
      9. Thailand
    4. Europe, Middle East & Africa
      1. France
      2. Germany
      3. Italy
      4. Netherlands
      5. Qatar
      6. Russia
      7. Saudi Arabia
      8. South Africa
      9. Spain
      10. United Arab Emirates
      11. United Kingdom
  11. 360iResearch Competitive Strategic Window
    1. Introduction
    2. 360iResearch Competitive Strategic Window, by Type
    3. 360iResearch Competitive Strategic Window, by Category
    4. 360iResearch Competitive Strategic Window, by End User
    5. 360iResearch Competitive Strategic Window, by Geography
  12. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. 360iResearch Market Ranking Analysis
    3. 360iResearch Market Share Analysis
    4. 360iResearch Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration, & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
      5. Award, Recognition, & Expansion
  13. Company Usability Profiles
    1. Bio-Manguinhos
    2. Chongqing Zhifei Biological Products Co., Ltd.
    3. GlaxoSmithKline PLC
    4. Hualan Biological Engineering Inc.
    5. Incepta Pharmaceuticals Ltd.
    6. Merck & Co., Inc.
    7. Pfizer Inc.
    8. Sanofi S.A.
    9. Serum Institute of India Ltd.
    10. Walvax Biotechnology Co., Ltd.
  14. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2017-2025 (USD MILLION)
  2. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  14. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  21. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  22. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  23. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  24. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  25. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  26. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  27. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  28. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  29. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  30. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  31. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  32. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  33. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  34. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  35. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  36. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  37. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  38. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  39. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  40. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  41. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  42. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  43. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  44. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  45. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  46. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  47. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  48. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  49. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  50. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  51. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  52. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  53. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  54. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  55. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  56. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  57. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  58. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  59. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  60. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  61. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  62. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  63. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  64. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  65. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  66. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  67. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  68. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  69. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  70. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  71. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  72. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  73. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  74. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  75. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  76. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  77. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  78. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  79. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  80. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  81. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  82. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  83. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  84. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  85. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  86. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  87. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  88. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  89. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  90. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  91. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  92. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  93. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  94. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  95. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  96. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  97. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  98. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  99. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  100. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  101. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  102. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  103. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  104. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  105. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  106. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  107. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  108. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  109. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  110. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  111. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  112. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  113. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  114. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2017-2025 (USD MILLION)
  115. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2017-2025 (USD MILLION)
  116. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  117. GLOBAL MENINGOCOCCAL VACCINES MARKET: SCORES
  118. GLOBAL MENINGOCOCCAL VACCINES MARKET: BUSINESS STRATEGY
  119. GLOBAL MENINGOCOCCAL VACCINES MARKET: PRODUCT SATISFACTION
  120. GLOBAL MENINGOCOCCAL VACCINES MARKET: RANKING
  121. GLOBAL MENINGOCOCCAL VACCINES MARKET: MERGER & ACQUISITION
  122. GLOBAL MENINGOCOCCAL VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  123. GLOBAL MENINGOCOCCAL VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  124. GLOBAL MENINGOCOCCAL VACCINES MARKET: INVESTMENT & FUNDING
  125. GLOBAL MENINGOCOCCAL VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
  126. GLOBAL MENINGOCOCCAL VACCINES MARKET: EDITION DETAILS
  127. GLOBAL MENINGOCOCCAL VACCINES MARKET: LICENSE DETAILS
  128. GLOBAL MENINGOCOCCAL VACCINES MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL MENINGOCOCCAL VACCINES MARKET: RESEARCH PROCESS
  2. GLOBAL MENINGOCOCCAL VACCINES MARKET: RESEARCH EXECUTION
  3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2019 VS 2025 (USD MILLION)
  5. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2019 VS 2025 (USD MILLION)
  6. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
  7. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  8. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MENINGOCOCCAL VACCINES MARKET, BY TYPE
  9. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2017-2025 (USD MILLION)
  10. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE GROWTH, 2017-2025 (USD MILLION)
  11. GLOBAL MENINGOCOCCAL VACCINES MARKET: MARKET DYNAMICS
  12. GLOBAL MENINGOCOCCAL VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
  13. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2019 VS 2025 (USD MILLION)
  14. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2019 VS 2025 (USD MILLION)
  15. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
  16. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  17. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  18. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  19. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2025
  21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2025
  22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2025
  23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
  24. GLOBAL MENINGOCOCCAL VACCINES MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  25. GLOBAL MENINGOCOCCAL VACCINES MARKET: 360IRESEARCH MARKET SHARE ANALYSIS